chr6-137158428-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052962.3(IL22RA2):c.116G>A(p.Arg39Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,613,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL22RA2 | NM_052962.3 | c.116G>A | p.Arg39Gln | missense_variant | 3/7 | ENST00000296980.7 | |
IL22RA2 | NM_181309.2 | c.116G>A | p.Arg39Gln | missense_variant | 3/6 | ||
IL22RA2 | NM_181310.2 | c.116G>A | p.Arg39Gln | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL22RA2 | ENST00000296980.7 | c.116G>A | p.Arg39Gln | missense_variant | 3/7 | 1 | NM_052962.3 | ||
IL22RA2 | ENST00000349184.9 | c.116G>A | p.Arg39Gln | missense_variant | 3/6 | 1 | P1 | ||
IL22RA2 | ENST00000339602.3 | c.116G>A | p.Arg39Gln | missense_variant | 3/5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152146Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251114Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135692
GnomAD4 exome AF: 0.0000376 AC: 55AN: 1461828Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 727222
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152146Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2021 | The c.116G>A (p.R39Q) alteration is located in exon 3 (coding exon 2) of the IL22RA2 gene. This alteration results from a G to A substitution at nucleotide position 116, causing the arginine (R) at amino acid position 39 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at